Allogeneic Hematopoietic Stem Cell Transplantation Clinical Trials

75 clinical trials for Allogeneic Hematopoietic Stem Cell Transplantation across international registries, including 15 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients — RECRUITING
• Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING
• Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE1
• Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE2
• Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING
• Nutrition OUtReach In Systems of Healthcare — RECRUITING · NA
• Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial — RECRUITING · PHASE4
• Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial — RECRUITING · PHASE3
• Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE2
• Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING
• Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention — RECRUITING · PHASE2
• Acupoint Application With Herbal Fumigation and Wash for Preventing Diarrhea-induced Perianal Infection in Allo-HSCT Patients — RECRUITING · NA
• Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome — RECRUITING · PHASE3
• Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study — RECRUITING
• Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING · NA
• Long-term Psychological and Cognitive Evaluation of Children Treated With Allogeneic Hematopoietic Stem Cell Transplantation for Immunodeficiency — NOT_YET_RECRUITING
• A Randomized Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation — NOT_YET_RECRUITING · NA
• Younger vs. Older Donors in Allo-HSCT: TTE — NOT_YET_RECRUITING
• Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics — COMPLETED · PHASE1
• Baricitinib for Post-HSCT Persistent Thrombocytopenia — NOT_YET_RECRUITING · PHASE1
• Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation — COMPLETED · PHASE3
• Perianal MBL-CRE Colonization and Infection in Allogeneic Hematopoietic Stem Cell Transplant Patients — NOT_YET_RECRUITING
• Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients — COMPLETED
• Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantation — COMPLETED
• Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. — NOT_YET_RECRUITING
• Virtual Reality Intervention for Symptom Management in Stem Cell Transplantation — NOT_YET_RECRUITING · NA
• Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation — ACTIVE_NOT_RECRUITING · PHASE1
• Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma — NOT_YET_RECRUITING · NA
• Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT — NOT_YET_RECRUITING
• A Phase II randomized trial of RSV vaccination in allogeneic hematopoietic stem cell transplant recipients (RSV-Allo study) — TERMINATED · PHASE3
• Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation — NOT_YET_RECRUITING
• BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients — NOT_YET_RECRUITING · PHASE3
• A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT — COMPLETED · PHASE1
• Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis — OTHER
• Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201) — OTHER
• Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study — OTHER
• Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT — OTHER · PHASE2
• Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT — OTHER · PHASE2
• G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT — OTHER · PHASE2
• MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation — COMPLETED · PHASE1
• Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation — OTHER · NA
• Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia — OTHER · NA
• Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202) — COMPLETED
• The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or Without Sorafenib Maintenance — OTHER
• The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT — OTHER
• The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT — OTHER
• G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT — OTHER · PHASE2
• Comparative Study of BFC and BuCy Conditioning Regimen for Allo-PBSCT in Acute B-cell ALL — OTHER · PHASE4
• Impact of the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Reunion Island Patients: Quality of Life, Determinants of Choices and Financial Repercussions — NOT_YET_RECRUITING
• BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT — COMPLETED · PHASE3

Refine this search